Hello, welcome to visit the official website of Chongqing Yusi Medicine Technology Co., Ltd.!

Y-PEG
Brand Yusi Pharma
IUPAC Name Fmoc-N-methyl-tetraethylene glycol-NHS ester
Abbreviations Fmoc-NH-PEG-NH2∙TFA NH2-PEG-Fmoc-TFA
Parameters
CAS Compound CID YD-PEG-4661
MF MW
Serial Number Norm Catalogue Price Stocks

Note: In the case of dangerous goods, low-temperature transport products, IATA products and other products that require special transport, freight and other related charges may be added according to the actual situation.

  • Product Information
I. [Product Description]
Fmoc-NH-PEG-NH2∙TFA is a highly reactive organic intermediate with both pharmaceutical intermediate and polymer material modification functions. Its core value lies in achieving efficient intermolecular coupling through the controllable PEG (polyethylene glycol) chain. Meanwhile, the fluorenylmethyloxycarbonyl (Fmoc) and NHS ester groups provide key connection sites for peptide synthesis and bioconjugation reactions.

II. [Product Details]
【Appearance】 Depending on different molecular weights, it appears as a white/off-white solid or a viscous liquid.
【Stability】 Store refrigerated and avoid repeated freeze-thaw cycles.
【Solvent】 Conventional organic solvents such as chloroform, dichloromethane, and DMSO.
【Molecular Weight】 (PEG): 2000, 3400, 5000. Other molecular weights can be customized.
【Storage Conditions】 Store in a sealed and dry condition at a low temperature below 4°C.
▪ Note: ▶ To ensure product stability, please open the package for use only after constant-temperature drying!

III. [Application Fields]
1. As a cleavable linker in solid-phase peptide synthesis (Reference: Organic Process Research & Development, 2021).
2. Hydrophilic modification of polymer material surfaces (Application Case: ACS Applied Materials & Interfaces, 2022).
3. Site-specific conjugation of biomolecules (e.g., proteins, antibodies) (Technical Verification: Bioconjugate Chemistry, 2020).
4. Functional modification of nanodrug carriers (Research Progress: Journal of Controlled Release, 2019).
5. Construction of signal amplification systems in in vitro diagnostic reagents (Patent Publication No.: WO2021155532A1).

Remarks: The products sold by our company are only used for scientific research and cannot be used in human experiments or human treatment.

Chongqing Yusi Pharmaceutical Technology Co., Ltd. operates based on an integrated R & D-production-sales business model, providing professional scientific research reagents for university scientific research experiments. Compared with similar products on the market, our company's products have obvious price advantages. In addition, we also provide professional product customization services.

If you need other products, please contact us:
Contact Information:
Landline: 023-62795528
Customer Service Hotline: 19112925095 丨 QQ: 3012135199
                                           18896157519 丨 QQ: 3354316092

Recommended Similar Products:
1. MAL-PEG-NHS (MW: 2000/3400/5000)
2. NH2-PEG-COOH (MW: 1000/2000/5000)
3. Boc-NH-PEG-NHS (MW: 3400/5000)
4. DBCO-PEG-NHS Ester (MW: 2000/5000)
5. Biotin-PEG-NHS (MW: 3400/5000)
6. FITC-PEG-NHS (MW: 2000/5000)
7. Acrylate-PEG-NHS (MW: 2000/3400)
8. SH-PEG-NHS (MW: 2000/5000)
9. Azide-PEG-NHS (MW: 3400/5000)
10. Cholesterol-PEG-NHS (MW: 2000/5000)
11. DSPE-PEG-NHS (MW: 2000/3400)
12. OPSS-PEG-NHS (MW: 3400/5000)
13. PLGA-PEG-NHS (MW: 2000/5000)
14. mPEG-NHS (MW: 2000/5000/10000)
15. Fmoc-PEG-NHS (MW: 3400/5000)

Sweep
Follow the public number

Sweep to follow the public number